These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23360637)

  • 1. Detection of a novel mutation in the GAA gene in an Iranian child with glycogen storage disease type II.
    Galehdari H; Emami M; Mohammadian G; Khodadadi A; Azmoon S; Baradaran M
    Arch Iran Med; 2013 Feb; 16(2):126-8. PubMed ID: 23360637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a clinical assay for detection of GAA mutations and characterization of the GAA mutation spectrum in a Canadian cohort of individuals with glycogen storage disease, type II.
    McCready ME; Carson NL; Chakraborty P; Clarke JT; Callahan JW; Skomorowski MA; Chan AK; Bamforth F; Casey R; Rupar CA; Geraghty MT
    Mol Genet Metab; 2007 Dec; 92(4):325-35. PubMed ID: 17723315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twenty-two novel mutations in the lysosomal alpha-glucosidase gene (GAA) underscore the genotype-phenotype correlation in glycogen storage disease type II.
    Hermans MM; van Leenen D; Kroos MA; Beesley CE; Van Der Ploeg AT; Sakuraba H; Wevers R; Kleijer W; Michelakakis H; Kirk EP; Fletcher J; Bosshard N; Basel-Vanagaite L; Besley G; Reuser AJ
    Hum Mutat; 2004 Jan; 23(1):47-56. PubMed ID: 14695532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical features and acid alpha-glucosidase gene mutation in 7 Chinese patients with glycogen storage disease type II].
    Liu Q; Zhao J; Wang ZX; Zhang W; Yuan Y
    Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(25):1981-5. PubMed ID: 24169249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype.
    Kroos MA; Pomponio RJ; Hagemans ML; Keulemans JL; Phipps M; DeRiso M; Palmer RE; Ausems MG; Van der Beek NA; Van Diggelen OP; Halley DJ; Van der Ploeg AT; Reuser AJ
    Neurology; 2007 Jan; 68(2):110-5. PubMed ID: 17210890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel GAA sequence variant c.1211 A>G reduces enzyme activity but not protein expression in infantile and adult onset Pompe disease.
    Nilsson MI; Kroos MA; Reuser AJ; Hatcher E; Akhtar M; McCready ME; Tarnopolsky MA
    Gene; 2014 Mar; 537(1):41-5. PubMed ID: 24384324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update of the pompe disease mutation database with 60 novel GAA sequence variants and additional studies on the functional effect of 34 previously reported variants.
    Kroos M; Hoogeveen-Westerveld M; Michelakakis H; Pomponio R; Van der Ploeg A; Halley D; Reuser A;
    Hum Mutat; 2012 Aug; 33(8):1161-5. PubMed ID: 22644586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two novel mutations in acid α-glucosidase gene in two patients with Pompe disease.
    Aykut A; Onay H; Kose M; Erbas Canda E; Karaca E; Coker M; Ozkinay F
    J Pediatr Endocrinol Metab; 2014 Nov; 27(11-12):1265-7. PubMed ID: 25026126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remarkably low fibroblast acid α-glucosidase activity in three adults with Pompe disease.
    Wens SC; Kroos MA; de Vries JM; Hoogeveen-Westerveld M; Wijgerde MG; van Doorn PA; van der Ploeg AT; Reuser AJ
    Mol Genet Metab; 2012 Nov; 107(3):485-9. PubMed ID: 23000108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silent exonic mutation in the acid-alpha-glycosidase gene that causes glycogen storage disease type II by affecting mRNA splicing.
    Maimaiti M; Takahashi S; Okajima K; Suzuki N; Ohinata J; Araki A; Tanaka H; Mukai T; Fujieda K
    J Hum Genet; 2009 Aug; 54(8):493-6. PubMed ID: 19609281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three patients with glycogen storage disease type II and the mutational spectrum of GAA in Korean patients.
    Park HD; Lee DH; Choi TY; Lee YK; Lee SY; Kim JW; Ki CS; Lee YW
    Ann Clin Lab Sci; 2013; 43(3):311-6. PubMed ID: 23884227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation detection in glycogen storage-disease type II by RT-PCR and automated sequencing.
    Hermans MM; van Leenen D; Kroos MA; Reuser AJ
    Biochem Biophys Res Commun; 1997 Dec; 241(2):414-8. PubMed ID: 9425285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genotype-phenotype correlation in Pompe disease.
    Kroos M; Hoogeveen-Westerveld M; van der Ploeg A; Reuser AJ
    Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):59-68. PubMed ID: 22253258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pompe disease (glycogen storage disease type II) in Argentineans: clinical manifestations and identification of 9 novel mutations.
    Palmer RE; Amartino HM; Niizawa G; Blanco M; Pomponio RJ; Chamoles NA
    Neuromuscul Disord; 2007 Jan; 17(1):16-22. PubMed ID: 17056254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update of the Pompe disease mutation database with 107 sequence variants and a format for severity rating.
    Kroos M; Pomponio RJ; van Vliet L; Palmer RE; Phipps M; Van der Helm R; Halley D; Reuser A;
    Hum Mutat; 2008 Jun; 29(6):E13-26. PubMed ID: 18425781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical characteristics and gene mutation analysis of one pedigree with infantile glycogen storage disease type II].
    Zhang L; Xu XH; Wang J; Zhang SJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Nov; 17(11):1228-31. PubMed ID: 26575883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a feasible assay for the detection of GAA mutations in patients with Pompe disease.
    Er TK; Chen CC; Chien YH; Liang WC; Kan TM; Jong YJ
    Clin Chim Acta; 2014 Feb; 429():18-25. PubMed ID: 24444888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen-storage disease type II (acid maltase deficiency): identification of a novel small deletion (delCC482+483) in French patients.
    Nicolino M; Puech JP; Letourneur F; Fardeau M; Kahn A; Poenaru L
    Biochem Biophys Res Commun; 1997 Jun; 235(1):138-41. PubMed ID: 9196050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of glycogen storage disease type II by enzyme replacement with a recombinant human acid maltase produced by over-expression in a CHO-DHFR(neg) cell line.
    Martiniuk F; Chen A; Donnabella V; Arvanitopoulos E; Slonim AE; Raben N; Plotz P; Rom WN
    Biochem Biophys Res Commun; 2000 Oct; 276(3):917-23. PubMed ID: 11027569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis and protein processing in late-onset Pompe disease patients with low levels of acid α-glucosidase activity.
    Bali DS; Tolun AA; Goldstein JL; Dai J; Kishnani PS
    Muscle Nerve; 2011 May; 43(5):665-70. PubMed ID: 21484825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.